chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I contracted pink eye and was treated with steroid drops around the same time as my shot. I believe it was 02/10 when my first pink eye symptoms appeared. My mother and son also had it a week prior so I was not alarmed. However, since then, I've been diagnosed with uveitis after the pink eye infection cleared, and have had continuous issues with extreme dry eye and vision changes. My eye doctor is thinking potentially an autoimmune issue, I'm seeing the diagnostic clinic to hopefully uncover this, but I've never had such eye issues before. I've had some eye fatigue that affected my vision in college due to sleep deprivation, but nothing like this. The chronic pain I'm dealing with has been worsened. This could be autoimmune and a random event, or it could be autoimmune undiagnosed that was trigger by the vaccine, or it could be just the vaccine. But since I believe in medicine and vaccines, I believe it is my duty to report the potential issue so that others and research could benefit from my experience should this be related.
Fatigue; tested positive after receiving Covid-19 vaccine; tested positive after receiving Covid-19 vaccine; severely congested; This is a spontaneous report from a Pfizer-sponsored program IBCC (Inbound Call Center for HCPs). A contactable consumer (patient) reported that a 47-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EJ1685, Expiry Date: Mar2021) via an unspecified route of administration at right deltoid on 20Dec2020 at single dose for COVID-19 immunization. Medical history included ongoing severe asthmatic diagnosed as a child. There were no concomitant medications. Patient (a front line worker) is Grief Counselor. She tested positive after receiving BNT162B2 on 29Dec2020. She was supposed to get the second dose on 10Jan2021. She was having fatigue since 01Jan2021 and was severely congested since 26Dec2020. She was asking if she should get the second dose. The outcome of the events severely congested and fatigue was recovering, of the other events was unknown.
LISTLESS; NO MOTIVATION; TIRED/SLUGGISH/FATIGUE; LIGHT HEADED/WOOZY; OFF-BALANCE/UNSTEADY; FEELING LOUSY; DEPESSED; OVERWHELMING ANXIETY/DREAD; LETHARGIC; EXHAUSTED. STILL EXPERIENCING EFFECTS THOUGH TO LESSER DEGREE.  UNABLE TO FOCUS/CONCENTRATE ON WORK ASSIGNMENTS...FEELING OF BEING IN A 'FOG'. WONDER ABOUT THE HOUSE AIMLESSLY.
Chills, Fever, Uncontrollable shaking, Fatigue, Nasuea
the third shoot  had more adverse effects than the previous two: Fever, severe muscle back all over my body, mood swing (like froggy bain) fatigue Time frame  3 days for all
Redness around injection about 6 inches around. Itching when it first appeared but now - mainly the redness.
Initial report was retrieved from the scientific literature on 06 September 2012. The following information is verbatim from the abstract: "Meningococci have historically caused extensive illness among members. Three successive meningococcal vaccine types were used from 1971 through 2010; overall disease incidence dropped by >90% during this period. During 2006-2010, disease incidence of 0.38 (cases per 100,000 person-years) among members was not significantly different from the incidence of 0.26 among the age-matched general population. Of the 26 cases, 5 were fatal, 15 were vaccine failures (e.g., illness in a person who had been vaccinated), and 9 were caused by Neisseria meningitidis serogroup Y. Incidences among 17- to 19-year-old were significantly higher than among comparison populations (p<0.05). No apparent change in epidemiology of meningococcal disease was observed after replacement of quadrivalent polysaccharide vaccine with conjugate vaccine in 2007. The data demonstrate that vaccination with meningococcal vaccine is effective." According to the report, the cases were confirmed by culture, PCR or both. The information included in this case concerns a 25-29-year-old female patient who had received MENACTRA (lot number, route, site and date of administration not reported) and 8 months after vaccination developed meningococcal meningitis, year reported as 2010 (Q 3). Neisseria meningitidis serogroup was determined to be serogroup C. Treatments were not reported. No further information was available at the time of report. Death was reported as "No", however the patient's outcome was not reported. The reporter for this case is the same as for cases 2012-08240, -08241, -08242, -08243, -08244, -08245, -08246, -08247, -08248, -08249, -08250, -08251, -08252, -08254, -08255, and -08256. Documents held by sender: None.
Received vaccine 4/11/2021 and woke up on 4/16/2021 with a generalized maculopapular rash.
pt recv vax & devel lump walnut size;had fever & was cranky 5 days later;Motrin brought fever down;
have sever pain my kidneys but not stones; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional and describes the occurrence of RENAL PAIN (have sever pain my kidneys but not stones) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No medical history was provided by the reporter.     On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On an unknown date, the patient experienced RENAL PAIN (have sever pain my kidneys but not stones). At the time of the report, RENAL PAIN (have sever pain my kidneys but not stones) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the event was not applicable. Med Info. AE reported. can this shoy make me have sever pain my kidneys but not stones.   Reporter did not allow further contact
Nausea- 2-3 days Fever above 100° for 2 and 1/2 days (note: highest 103° Chills Tight chest General blahs Tired Sleeping
Patient received booster dose 13 days prior to 6 months. No adverse symptoms noted. Patient made aware of the situation via the phone after event was discovered.
Patient reports adverse events of fever, goosebumps and shakes. Fever 100.4 over face and neck and she also has body aches. This has become increasingly worse. Patient has been taking Ibuprofen (4 does in  the last 24 hours) and also reports arm pain to the point that she cannot lift her arm.
Vaccine brand other: Novavax; Vaccine brand: Pfizer/BioNTech; Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 72-year-old female patient (not pregnant) received bnt162b2, bnt162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 08Sep2022 at 12:00 as dose 3 (booster), single (Lot number: GH9694) at the age of 71 years, in left arm for covid-19 immunisation; covid-19 vaccine prot. subunit (nvx cov 2373) (NOVAVAX COVID-19 VACCINE), on 14Oct2023 at 12:00 as dose number unknown, single (Lot number: 5683MF012), in right arm for covid-19 immunisation; covid-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Oct2023, outcome "recovered" and all described as "Treatment of COVID-19"; INTERCHANGE OF VACCINE PRODUCTS (medically significant), outcome "recovered", described as "Vaccine brand other: Novavax; Vaccine brand: Pfizer/BioNTech". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (Oct2023) Negative. Therapeutic measures were taken as a result of drug ineffective, Covid-19 with Paxlovid from 27Oct2023 to 31Oct2023.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300357527 same patient, different drug and event;
Cellulitis 9 cm x 6 cm surrounding vaccine sites on (L) thigh.
Gradual ringing noise in her right ear; Light-headed; Felt loss of balance; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (Gradual ringing noise in her right ear), DIZZINESS (Light-headed) and BALANCE DISORDER (Felt loss of balance) in a 92-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced TINNITUS (Gradual ringing noise in her right ear), DIZZINESS (Light-headed) and BALANCE DISORDER (Felt loss of balance). The patient was treated with BENZOCAINE, PHENAZONE (EAR DROPS RX) for Tinnitus, at an unspecified dose and frequency. At the time of the report, TINNITUS (Gradual ringing noise in her right ear) had not resolved and DIZZINESS (Light-headed) and BALANCE DISORDER (Felt loss of balance) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported.   This case was linked to MOD-2021-304876 (Patient Link).
Hives left side of neck, arm and under left armpit treated with Benadryl over 72 hours, developed shortness of breath and tightness of chest.  Albuterol neb & inhaler were used.  Aspirin taken Sat, Mon, Wed, Friday.  Followed up with urgentcare on 10/23.  Additional Albuterol prescribed and xray ordered due to wheezing in left side following MD assessment.  Rest
This spontaneous report has been received from a nurse practitioner regarding a patient of unknown age or gender. The patient's concurrent condition, medical history and concomitant medications were not reported. On an unknown date, the patient was vaccinated VARIVAX dose 1, (dose, lot # and expiry date unknown). On 02-MAY-2011, patient received improperly stored VARIVAX dose 2, from lot # 0552Z (expiry date not reported). No adverse effects were reported. The reporter stated that inconsistencies in storage temperature were identified on extensive review and records. The reporter stated that vaccine was not thawed. The nurse practitioner reported that there was insufficient data to provide 100 percent assurance on vaccine stability. This is one of the several reports received from the same reporter. Additional information has been requested.
Decreased responsiveness for 2-3 hrs /p vaccine approx. 12-24 /p vaccine given. "Somewhat limp & pale" but arousable. Spontaneously resolved, Seen pm 20Jun90 with normal exam at office
Patient came into the Pharmacy on 3-6-19 to mention that after the vaccine he started to develop pressure and congestion in his ears with a persistent ringing in the ears. On 3-7-19 he came back to pick up an electronic Rx for Valacyclovir as he went to a clinic because it was not getting better, and he was starting to have discomfort down his jaw and what felt like a sore in his mouth towards the back of the tongue.
pt recv vax recv HIBTITER & TETRAMUNE on the same day & exp sleepiness & redness @ the site of HIBTITER;pt recovered;
Fever of 99.8 F; Fatigue; Dizzyness; Headache; Body aches
8/19 approximately 8pm (Headache, Backache, Nausea)->TYLENOL/ondansetron, ranitidine. 8/20 approximately 11am (Headache-migraine like pain) TYLENOL, sinus meds. Approximately 11pm (migraine back, backache) PERCOCET/ondansetron. 8/21 approximately 9pm (migraine, nausea, muscle aches->vomiting).
mild metallic taste; poor administration tech; extreme burning for 10 min following vax-I; arm soreness; This is a spontaneous report from a contactable nurse (patient). A 55-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number EK5730), via an unspecified route of administration on 21Dec2020 11:30 at single dose for covid-19 immunization. Vaccine location was left arm and it was the first dose. Patient is not pregnant. The facility type vaccine was Workplace clinic. Medical history included obesity from an unknown date. Known allergies included sulfa and penicillin. Concomitant medication included metoprolol, vitamin d3, calcium, probiotics. Patient was not diagnosed with COVID-19 prior to vaccination. The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced mild metallic taste on 22Dec2020 11:30 with outcome of recovered, arm soreness on 21Dec2020 with outcome of recovered, poor administration tech on 21Dec2020 11:40 with outcome of recovered, extreme burning for 10 min following vax-i on 21Dec2020 11:40 with outcome of recovered. The verbatim as follow: 1st Vax: mild metallic taste and arm soreness (including extreme burning for 10 min following vax-I believe this was poor administration tech), slight metallic taste 24 hrs post vax, lasted a few hours. Patient didn't receive treatment for the adverse events. The patient underwent lab tests and procedures which included sars-cov-2 test: negative on 04Jan2021. The covid test type post vaccination was Nasal Swab. The covid test name post vaccination was PCR.
muscle aches; pain /  it hurt everywhere; nausea; being very sick from vaccine and felt like dying; felt like dying; This case was reported by a consumer via call center representative and described the occurrence of muscle pain in a 76-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix (intramuscular). On an unknown date, less than a day after receiving Shingrix, the patient experienced muscle pain, pain, nausea, sickness and impending doom. On an unknown date, the outcome of the muscle pain, pain, nausea, sickness and impending doom were recovered/resolved.   The reporter considered the muscle pain, pain, nausea, sickness and impending doom to be related to Shingrix.  Additional details were reported as follows: This case was reported by patient himself. In December 2020 or January 2021 (2 to 3 months ago), the patient received 1st dose of Shingrix and reported being very sick from vaccine and felt like dying. The patient explained her actual symptoms by describing that she experienced muscle aches, pain, and nausea and also stated that it hurt everywhere. The patient reported that all of these symptoms started on the late afternoon she received the vaccine and resolved the next day. The reporter did not consent to follow-up. No other information was reported.
FRONTAL HEADACHE 6/10 PAIN.  LIGHTHEADED.  TX'D C/ OBSERVATION AND TYLENOL.
pain in arm, within 5 days-very tired and no apatite, fever/chills/cold sweats. within 30 days,  sinus tachycardia, low Sp02, started having a cough.  Sepsis secondary to severe right lung necrotizing pneumonia with empyema, hospitalized for 5 days. Discharged with a right chest tube with  Pleur-evac. Will require at least 6 weeks of antibiotics.
Generalized muscle spasms and twitches all over my body; Generalized muscle spasms and twitches all over my body; Gets worse when tired.; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 42 year-old male patient received bnt162b2 (BNT162B2), administered in arm right, administration date 21Mar2021 16:30 (Lot number: EN6208) at the age of 42 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "ADHD" (unspecified if ongoing); "GERD" (unspecified if ongoing); "tourettes" (unspecified if ongoing). Concomitant medication(s) included: XANAX; TRILEPTAL; FOCALIN XR ER; TYLENOL. Past drug history included: Fruits, notes: Fruits. The following information was reported: MUSCLE SPASMS (non-serious), MUSCLE TWITCHING (non-serious) all with onset 22Mar2021 08:00, outcome "not recovered" and all described as "Generalized muscle spasms and twitches all over my body"; FATIGUE (non-serious) with onset 22Mar2021 08:00, outcome "not recovered", described as "Gets worse when tired.". The events "generalized muscle spasms and twitches all over my body", "generalized muscle spasms and twitches all over my body" and "gets worse when tired." were evaluated at the physician office visit.  Additional information: Facility where the most recent COVID-19 vaccine was administered was hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Other medications the patient received within 2 weeks of vaccination included Trileptal, Focalin, Tylenol, Xanax. Prior to vaccination, the patient was not diagnosed with COVID-19; Since the vaccination, the patient has not been tested for COVID-19. Adverse event resulted in doctor or other healthcare professional office/clinic visit. The patient experienced generalized muscle spasms and twitches all over my body starting 1 hour after the 1st dose, worst the next day. Primarily in legs, but also arms neck and face and eye area. Almost continuous, every day since. Gets worse when tired. Never experienced similar before. The patient also received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/lot number:ER8737, Expiry date: unknown), via an unspecified route of administration, administered on 11Apr2021 at 16:30 in Arm Left as dose 2, single for covid-19 immunisation.  No follow-up attempts are possible. No further information is expected.
Knee pain - left knee. Went to the doctor - it's believed to be a torn Meniscus. I'm going to have an MRI done.  MRI scheduled for June 29th, 2021. No treatment. The pain comes and goes - it's not constant. It occasionally is painful enough that I limp.
At 4 mo PE, pt's mother stated that, pt stopped cooing after receiving the PENTACEL and ROTARIX vaccines 8/13/14. Pt was also noted not to smile as much. This change continued until 9/7/14.
Pt. had his meningitis injection 3/30/23 2 days later he had neck pain and left shoulder pain He lifted a drum and then he felt a pain like he pulled a muscle and then after that he could not move his neck. He used ice and switched out the pillows and it has not helped It got better and went away for a week and then it came back again. He has pain that is 3/10 right now.  He feels a tension that does not allow him to turn his neck.
Where pneumovax given: red warm spot reported 2 days after receiving vaccine, "passed out" - did not hurt himself. Went to MD - taking Keflex for infection.
pt recvd vax; arm red, swollen & hot; next day pt had flu sxs;
General weakness; Nauseous; Intermittent dizzyness; This spontaneous case was reported by a patient and describes the occurrence of DIZZINESS (Intermittent dizzyness), ASTHENIA (General weakness) and NAUSEA (Nauseous) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 050C214) for COVID-19 vaccination.     Concomitant products included TELMISARTAN and AMLODIPINE for Hypertension.    On 26-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1. On 26-May-2021, the patient experienced DIZZINESS (Intermittent dizzyness) and NAUSEA (Nauseous). On 28-May-2021, the patient experienced ASTHENIA (General weakness). At the time of the report, DIZZINESS (Intermittent dizzyness), ASTHENIA (General weakness) and NAUSEA (Nauseous) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details were not provided.
Numbness in toes often most noticeable upon waking. In addition, a decrease in circulation in the same toes where numbness occurs. There has been no improvement of symptoms, only a cycling from a greater to lesser degree.
This spontaneous report as received from a pharmacist refers to a 54 years old female patient with allergies to iodinated contrast media, allergies to indomethacin. The patient was vaccinated with ZOSTAVAX (0.65 ml, lot # 0256AE, expiration date 14-MAR-2013) on 28-JUN-2012. Concomitant therapy included VALTREX, it prescribed on 30-APR-2012 for the flu, not in sufficient quantity for the patient to have still been taking it at the time of ZOSTAVAX administration. The patient returned to the pharmacy on 06-AUG-2012. Approximately on 23-JUL-2012 the patient "flu from hell for the past two weeks" and experienced chills, low body temperature of 93.5 degrees Fahrenheit, vomiting for 320 hours, dehydration, severe headache and severe joint aches. The patient was hospitalized at an unspecified facility on unspecified dates. The outcome was reported as recovered/resolved. The patient sought medical attention because she was hospitalized. Additional information has been requested.
Initial unsolicited report received from a physician on 13-Oct-2017. This case involves female patient of unknown age who was vaccinated with dose of FLUZONE ID batch number: UT5902AA (expiry date, dose, dose in series, route and site of administration were not reported) on an unknown date. Patient's medical history and concomitant medications were not reported. On an unknown date, following the vaccination, patient experienced pain at injection site radiating up arm and into neck, described as having crick in neck. Lab data and corrective treatment were not reported. Event outcome was not reported. List of documents held by sender: none.
Information has been received on 02-JUL-2018 regarding a case in litigation from a lawyer and a female consumer of unknown age. The patient's concurrent conditions, medical history and concomitant medications are unknown. On or about 07-MAY-2016, the patient was inoculated with ZOSTAVAX (lot number and expiration unknown) unknown route at a medical center as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster. On or about 15-JUL-2016, the patient was treated at a medical center for a vesicular outbreak, which was diagnosed as herpes zoster, or shingles. As a direct and proximate result of the ZOSTAVAX and/or despite receiving the ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses and pain and suffering and other damages. Additional information has been requested.
Patient received Moderna #2 vaccine after getting Pfizer #1 the previous month, and experienced negative side effects in the 15 minute monitoring period. Details as follows:  - Patient booked and appointment for Moderna Vaccine #2 with no record of previous #1 vaccine. Upon arrival, we asked to produce their vaccination card, but they did not have it. As such, prior to administering, we verified clinical background and confirmed with them that they were getting the Moderna #2, which they confirmed yes.  - After administration, during the 15 minute monitoring period, patient reported having increased heartrate, chest discomfort, and nausea. Stated having history of similar reactions to vaccines/injections and anxiety increasing during these. - Patient was asked to wait 15 more minutes.  - After 15 more minutes, patient symptoms had not completely subsided. As a result, we informed the patient they should not drive/leave alone, should have someone with them, and that they should see a medical provider immediately if their symptoms did not subside/worsen.  - Afterwards, patient stated that they had actually gotten Pfizer vaccine in the previous month. Explained to them that the difference vaccine is the reason why they reacted more negatively to a difference vaccine. Re-emphasized that patient should not leave alone and to see a medical provider ASAP if symptoms did not go away/worsened. - Patient confirmed they had somebody to drive/monitor them and left after acknowleding that they should go to ED if symptoms remain.
patient received undiluted vaccine at a dose of approximately 20mcg (double the intended dose).  Patient's mother contacted on 7/21/22 and reported no adverse effects.